Advertisement

Yambaling Hydropower Limited (YMHL)

Hydropower · Rs. 449.00 -13.00 (-2.81%) as of Oct 16, 2026

Price — last 6 months

Full chart →
Open
462.00
High / Low
469.00 / 448.20
Prev. close
462.00
Volume
14,228
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding—
Public holding—

Stock performance

1-week change
-9.27%
1-month change
-19.10%
3-month change
-23.65%
6-month change
—
YTD change
—
1-year change
—
1-month high
598.00
1-month low
448.20
From 52-week high
—
From 52-week low
—
180-day avg price
574.64
360-day avg price
574.64
Avg volume (1w)
12,478
Avg volume (1m)
22,236
Avg volume (6m)
24,968
Avg volume (12m)
24,968
Daily volatility (1m)
2.47%
Beta vs NEPSE (1y)
1.31

Valuation

EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Hydropower

EPS (Rs.)
N/A
min -29.72avg 4.88max 29.72
—
P/E
N/A
min 19.95avg 107.26max 664.35
—
P/B
N/A
min 2.40avg 4.43max 32.11
—
Networth / Share (Rs.)
N/A
min -25.60avg 101.08max 210.87
—
ROE (%)
N/A
min 0.00avg 6.11max 65.79
—

Technical indicators

RSI (14)24.97Oversold
MACD-29.96Bearish
EMA 5464.48Bearish
EMA 20503.08Bearish
EMA 180——
SMA 50564.23Bearish
SMA 200——
Pivot levels (classic)
S3
421.00
S2
434.60
S1
441.80
PP
455.40
R1
462.60
R2
476.20
R3
483.40

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Hydropower stocks

YMHL — frequently asked questions

What is Yambaling Hydropower Limited's share price?

Rs. 449.00 as of Oct 16, 2026, the latest NEPSE trading session (-2.81% on the day).

What dividend did YMHL pay?

No dividend on record for the most recent fiscal year in our data.

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.